Notice Announcing Pre-application Information Webinar for Clinical Sequencing Evidence-generating Research (CSER2) Requests For Applications (RFAs) and Frequently Asked Questions (FAQ) regarding Clinical Sequencing Funding Opportunities

Notice Number: NOT-HG-16-021

Key Dates
Release Date: June 2, 2016

Related Announcements

Issued by
National Human Genome Research Institute (NHGRI)


On April 19 and May 6, 2016, the NIH issued the following Funding Opportunity Announcements (FOAs):

  • PAR-16-209, Investigator-Initiated Clinical Sequencing Research (R01)
  • RFA HG-16-010, Clinical Sequencing Evidence-Generating Research (CSER2) - Clinical Sites (U01)
  • RFA HG-16-011, Clinical Sequencing Evidence-Generating Research (CSER2) - Clinical Sites with Enhanced Diversity (U01)
  • RFA HG-16-012, Clinical Sequencing Evidence-Generating Research (CSER2) Coordinating Center (U24)

To assist potential applicants to the above-referenced FOAs, this Notice provides the following information:

  • A Pre-application Information Webinar for potential CSER2 applicants will be provided on June 15, 2016.
  • A FAQs page is available to prospective applicants.

CSER2 Webinar Information

Date: Wednesday, June 15th, 2016
Time: 3:00 4:00 PM EDT

The intent of the pre-application webinar is to provide an overview of the CSER2 FOAs and to address questions pertinent to preparing applications. The webinar is optional and not required for application submission.

NHGRI staff will post information about how to participate in the Webinar at Prospective applicants are encouraged to submit their questions or comments regarding the RFA to before Monday, June 13th. Afterwards, slides of the Webinar will be posted on the same website.

Prospective applicants with inquiries concerning the FOAs who are unable to participate in the Webinar are encouraged to view the summary of questions and answers after the Webinar. For any additional questions, contact the Scientific/Research contacts listed in RFA-HG-16-010, RFA-HG-16-011, and RFA-HG-16-012.


As a result of discussions with potential applicants to CSER2 FOAs and PAR-16-209, NHGRI has generated a document of Frequently Asked Questions (FAQs) and answers ( This FAQ may be updated with additional questions and answers without additional notice.


Please direct all inquiries regarding this Notice to:

Lucia A. Hindorff, PhD, MPH
National Human Genome Research Institute
Telephone: 240-271-1509